The latest meta-analysis on the use of erythritopoiesis-stimulating agents in chemotherapy induced anaemia brings new light on the safety

In this current issue of Lung Cancer, Vansteenkiste et al. (1) report the results of 2 meta-analysis on the benefits and risks of using erythropoieis-stimulating agents (ESAs) in lung cancer patients.